Novel Prognostic Groups in Thymic Epithelial Tumors: Assessment of Risk and Therapeutic Strategy Selection

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 2, 2008, Pages 420-427

  D'Angelillo, Rolando M ^a   Trodella, Lucio ^a   Ramella, Sara ^a   Cellini, Numa ^b   Balducci, Mario ^b   Mantini, Giovanna ^b   Cellini, Francesco ^a   Ciresa, Marzia ^a   Fiore, Michele ^a   Evoli, Amelia ^b   Sterzi, Silvia ^a   Russo, Patrizia ^c   Grozio, Alessia ^c   Cesario, Alfredo ^d,e   Granone, Pierluigi ^d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Masaoka stage; Prognostic classes; Thymic epithelial tumor; Thymoma; WHO classification; World Health Organization

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY; RISK ASSESSMENT; SURGERY;

PROGNOSTIC CLASSES; THYMECTOMY; THYMIC EPITHELIAL TUMOR;

TUMORS;

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL DECISION MAKING; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; THYMECTOMY; THYMOMA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGUS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THYMOMA; THYMUS NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 43049152821     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.10.006     Document Type: Article

References (27)

1. Fornasiero A., Daniele O., Ghiotto C., et al. Chemotherapy of invasive thymoma. J Clin Oncol 8 (1990) 1419-1423
2. Masaoka A., Monden Y., Nakahara K., et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
3. Rosai J., and Sobin L. Histological typing of tumours of the thymus. In: World Health Organization (Ed). International histological classification of tumours (1999), Springer, Heidelberg 1-16
4. Riedel R.F., and Burfeind Jr. W.R. Thymoma: Benign appearance, malignant potential. Oncologist 11 (2006) 887-894
5. Rena O., Papalia E., Oliaro A., et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?. Eur J Cardiothorac Surg 31 (2007) 109-113
6. Cesaretti J.A. Adjuvant radiation with modern techniques is the standard of care for stage III thymoma. Ann Thorac Surg 81 (2006) 1180-1181
7. Mangi A.A., Wain J.C., Donahue D.M., et al. Adjuvant radiation of stage III thymoma: Is it necessary?. Ann Thorac Surg 79 (2005) 1834-1839
8. Zhu G., He S., Fu X., et al. Radiotherapy and prognostic factors for thymoma: A retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 60 (2004) 1113-1119
9. Ströbel P., Bauer A., Puppe B., et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis. J Clin Oncol 22 (2004) 1501-1509
10. Koga K., Matsuno Y., Noguchi M., et al. A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44 (1994) 359-367
11. Jaretzki III A., and Wolff M. "Maximal" thymectomy for myasthenia gravis: Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 96 (1998) 711-716
12. Perez C.A., and Brady L.W. Principles and practice of radiation oncology (1992), JB Lippincott, Philadelphia p. 51-55
13. Wright C.D., Wain J.C., Wong D.R., et al. Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
14. Ströbel P., Marx A., Zettl A., et al. Thymoma and thymic carcinoma: An update of the WHO classification 2004. Surg Today 35 (2005) 805-811
15. Chen G., Marx A., Wen-Hu C., et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
16. Uemura M., Higashiyama M., Okami J., et al. Intrapulmonary metastasis developing eighteen years after complete resection of thymoma. Jpn J Thorac Cardiovasc Surg 54 (2006) 289-292
17. Mineo T.C., Ambrogi V., Mineo D., et al. Long-term disease-free survival of patients with radically resected thymomas: Relevance of cell-cycle protein expression. Cancer 104 (2005) 2063-2071
18. Rea F., Marulli G., Girardi R., et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 26 (2004) 412-418
19. Sonobe S., Miyamoto H., Izumi H., et al. Clinical usefulness of the WHO histological classification of thymoma. Ann Thorac Cardiovasc Surg 11 (2005) 367-373
20. Fang W., Chen W., Chen G., et al. Surgical management of thymic epithelial tumors: A retrospective review of 204 cases. Ann Thorac Surg 80 (2005) 2002-2007
21. Park M.S., Chung K.Y., Kim K.D., et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 78 (2004) 992-997
22. Rena O., Papalia E., Maggi G., et al. World Health Organization histologic classification: An independent prognostic factor in resected thymomas. Lung Cancer 50 (2005) 59-66
23. Kim D.J., Yang W.I., Choi S.S., et al. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: A clinicopathologic study of 108 patients and literature review. Chest 127 (2005) 755-761
24. Zisis C., Rontogianni D., Tzavara C., et al. Prognostic factors in thymic epithelial tumors undergoing complete resection. Ann Thorac Surg 80 (2005) 1056-1062
25. Loehrer Sr. P.J., Jiroutek M., Aisner S., et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: An Intergroup trial. Cancer 91 (2001) 2010-2015
26. Giaccone G., Wilmink H., Paul M.A., et al. Systemic treatment of malignant thymoma: A decade experience at a single institution. Am J Clin Oncol 29 (2006) 336-344
27. Evoli A., Minisci C., Di Schino C., et al. Thymoma in patients with MG: Characteristics and long-term outcome. Neurology 59 (2002) 1844-1850